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ABSTRACT 
Ribose 5 ' -phosphate Aminotransferase of Salmonella typhimurium 
by 
Gulamnabi Y. Vahora, Master of Science 
Utah State University, 1971 
Major Professor: Dr. Carl A. Westby 
Department: Bacteriology and Public Health 
Ribose-5 '-phosphate aminotransferase, an alternate first enzyme in the 
purine de novo pathway, has been purified about 800-fold from Salmonella 
typhimurium (pur D-55 ). The enzyme is distinct from ribosylpyrophosphate-
5' -phosphate amidotransferase (E C 2. 4. 2.14), has an approximate molecular 
weight of 229,000, and requires ribose-5'-phosphate, ATP and either ammonium 
ion, carbamyl phosphate or L-glutamine, to synthesize 5'-phosphoribosylamine 
(PRA). A coupled assay system, employing a§_. typhimurium (pur G-310) ex-
tract as the coupling-agent source, was used to measure the enzyme. PRA pro-
duction in this system was inhibited by higher ribose-5' -phosphate concentrations 
and longer (over 10 minutes) incubation periods. It is proposed that an alternate 
pathway for the initial step of purine biosynthesis exists in§_. typhimurium, 
namely, the direct conversion of ribose-5 '-phosphate and ammonium ion to PRA. 
(50 pages) 
INTRODUCTION 
Free purine and pyrimidine nucleotides are present intracellularly in 
all forms of life and serve as major components of nucleic acids as well as 
many co-enzymes . The study of the biosynthesis of these compounds conse-· 
quently has lead to an understanding of the universality of life. 
One approach to the study of purine biosynthesis followed by a goodly 
number of investigators (1, 5, 8, 24, 34, 36, 60) has been to examine the 
enzymes of the pathway. Perhaps the first-step enzyme, PP-ribose-P amido-
transferase, has received the most attention in this regard because of its 
dominant role in regulation of the pathway. 
This study, on the other hand, reports on an alternate first enzyme of 
the pathway, ribose-5 '-phosphate aminotransferase, catalyzing the reaction: 
+ Ribose-5 '-phosphate + NH
4 
+ ATP 
ADP + Pi 
Phosphoribosylamine (PRA) + 
The aminotransferase was purified from the cell-free extract of a 
S. typhimurium mutant (Pur D- 55) lacking the second de novo enzyme, 
(glycinamide ribotide synthetase) GAR synthetase, and various of its physical 
and biochemical properties were examined . The results of the study confirm 
the assertions of earlier investigations on the existence of an alternate first 
2 
enzyme. The significance of non-enzymatic PRA formation (45) in 
§_. typhimurium now must be re-examined in light of the present study . 
3 
REVIEW OF LITERATURE 
The 12&, Novo Synthesis of Purine Nucleotides 
In the past four decades great numbers of investigators have labored 
to elucidate the biosynthesis of purine nucleotides in avian (22, 48 , 64), tumor 
(26, 29), plant (32), and microbial systems ( 1, 12, 17, 34, 43, 51, 56, 60). 
If it were not for the early emphasis that was given to studies on avian liver, 
microorganisms might have played a more prominent role in the initial dis-
coveries on purine biosynthesis because purine auxotrophic mutants of bacteria 
were available early and could have been gainfully employed in Beadle-Tatum 
(2) types of biosynthetic analyses. As it happened, however, the first studies 
of purine biosynthesis were in avian liver systems, the most important of these 
being the works of Schuler and Reindel (53) in 1935, and Edson et al. (11) and 
Orstrom et al. (47) in 1936 and 1939, respectively. The particularly important 
effort of Krebs and coworkers to synthesize purines de novo in pigeon liver 
slices was the first synthetic study of the pathway at the in vitro level. 
Hypoxanthine was produced in vitro for the first time in this study, and its 
synthesis was stimulated by oxaloacetate and L-glutamine (47), suggesting that 
the nitrogen base was being formed de novo rather than as a result of a break-
down of a pre-formed purine. 
The first tissue and cell free system capable of carrying out hypoxanthine 
synthesis was constructed by Greenberg (18), using pigeon liver extract. His 
4 
results indicated that inosinic acid was the first purine compound formed and it 
was then further catabolized to inosine, hypoxanthine, or uric acid. The work 
of Greenberg (18, 19) also suggested that purine bases were synthesized from 
simpler phosphoribosyl derivatives such as ribose-5 '-phosphate. 
The incorporation of radioactivity into uric acid from labeled CO
2
, 
formate and glycine in in vivo studies (7, 8, 20, 57, 58) indicated that carbon 6 
of uric acid was derived from CO
2
, carbon 2 and 8 from formate and carbon 4, 
5, and nitrogen 7 from, respectively, the carboxyl carbon, the CX carbon and 





labeled compounds in the body pools of pigeons, the 
origin of nitrogen atoms 1, 3, and 9 of uric acid could not be definitely deter-
mined by in viv~ studies . Levenberg et al. (36) were able to establish the exact 
origins of these nitrogen atoms, however, by analyzing the degradation products 
of uric acid and it was ascertained that nitrogen 1 was derived from aspartic 
acid, and nitrogen atoms 3 and 9 were derived from the amide nitrogen of 
glutamine. 
The other naturally occurring purines were thereafter shown to be 
synthesized in a similar fashion (5). Figure 1 summarizes the current state 
of information. 
The Formation of fl-D-Phosphoribosylamine (PRA) . 
The initial steps of de novo purine nucleotide synthesis were largely 
worked out by Goldthwait (13), Goldthwait et al. (14), Levenberg et al. (36), 
RIBOSE-5 - PHOSPHATE 
Figure 1. The origin of the carbon and nitrogen atoms of the purine, inosinic acid. 
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Buchanan and Hartman (6), Hartman and Levenberg (25), Lukens and Flaks (38), 
and Greenberg (18, 19), in in vitro av ian liver studies of the 1950's. 
Kornberg et al. ( 33), and Remy et al. (50), suggested from their studies 
that the purine biosynthetic pathway was initiated by the formation of 5'-phos -
phoribosylpyrophosphate (PP- ribose- P) from ribose-5'-phosphate and AT P 
through the mediation of 5 ' -phosphoribose-pyrophosphokinase (EC 2.7.6 . 1). 
The formation of j?-D-phosphoribosylamine (PRA) from PP-ribose-P and 
L-glutamine was shortly thereafter shown to be the next reaction (22, 26, 49), 
however, recently an alternate synthesis of PRA from ribose-5' -phosphate and 
ammonium ion was demonstrated in some of the same systems (29, 32, 34, 45, 
48), thus revealing a previously undetected convergence in the de nova pathway. 
Details of the alternate routes to PRA are indicated in equations 1 and 2. 
1. PP-ribose-P 
+ 
ribosylpyrophosphate 5 '-amidotransferase ) PRA + PP + 
(EC 2· 4· 2. 14) L-glutamate 
L- glutamine 




PRA + ADP 
ribose - 5'-phosphate aminotransferase> + Pi + H
2
o 
Ribo sy lpyropho sphate 5 '-Amidotr ansf er as e 
The PP-ribose-P amidotransferase mediated formation of PRA from 
PP-ribose- P, L-glutamine, -magnesium ion, and ATP is evidenced in plant 
(32), animal (26, 29, 30, 49), avian (5, 9, 22, 64) and bacterial systems (17, 
43, 51, 56). The amide group of L-glutamine seems to serve as the primary 
7 
amino source of PRA in pigeon liver (22, 24) and bacteria (17, 43, 51, 56), 
whereas in plants (32) (wheat embryo) the amide group of L-asparagine serves 
this role. 
The amidotransferase has been purified from pigeon liver (9, 21, 22)J 
ascites tumor (4, 35) and Aerobacter aerogenes (43) approximately 1000-, 
20- and 12-fold, respectively. The avian liver enzyme has a molecular weight 
of about 200,000, contains non-heme iron (9, 21) and has a sedimentation 
coefficient of 9 S (9 to 11 S for crude enzyme preparation). Rowe and Wyngaarden 
(52) have reported that the enzyme dissociates rapidly into 100, 000 molecular 
weight subunits and that these, in the presence of thiols, dissociate into 50, 000 
molecular weight subunits or monomers, which are identical electrophoretically. 
Each 100,000 molecular weight subunit or dimer, contains 6 non-heme iron 
atoms, some of which are involved in the catalytic reaction and some of which 
serve primarily a structural function. The visible absorption spectrum of the 
enzyme reveals a maximum at 415 m}1, which disappears with the removal of 
iron from the protein. 
The pigeon liver enzyme contains two separate regulatory sites, one 
for 6-amino and one for 6-hydroxy purine ribonucleotides (22, 23). Mixtures 
of two non-homologous types of purine ribonucleotides affect a cooperative 
inhibition on the enzyme (22, 23). It is postulated that the purine ribonucleotides 
function as allosteric regulators, binding at sites on the enzyme molecule 
distinct from the active site and inducing a conformational change in the enzyme 
that renders it catalytically less effective by reducing its substrate affinity (59). 
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Ribose-5' -Phosphate Aminotransferase 
The direct enzymatic synthesis of PRA from ribose-5'-phosphate, ATP 
and ammonium ion was first suggested by the work of Nierlich and Magasanik in 
bacterial studies involving A. aerogenes (43). Later the same authors concluded 
from other evidence that the PRA synthesis they were observing was completely 
non-enzymic (45), and the ATP requirement was an artifact. Le Gal and co-
workers (34) in Escherichia coli studies have since presented opposing evidence, 
suggesting that PRA is synthesized in vivo from ribose-5'-phosphate and 
ammonium ion, for the most part, through an enzyme reaction. Other workers 
also have evidence of such an enzymic synthesis of PRA in other systems (12, 
27, 28, 29, 32). Reem (48), for example, has shown that the alternate synthesis 
of PRA in avian liver occurs only when ribose-5'-phosphate, ATP, magnesium 
ion, an ammonium ion donor, and an enzyme which is separate and distinct 
from PP-ribose-P amidotransferase are present. Furthermore, the demon-
stration of a feed-back sensitivity suggests that the enzymes' role is similar 
to that of PP-ribose·-P amidotransferase in the regulation of purine biosynthesis. 
The involved enzyme, termed "ribose-5' -phosphate aminotransferase," was 
purified by Reem approximately 100-fold from duck, chicken, and pigeon liver, 
and it demonstrated only half the activity of the liver amidotransferase (per 
mg protein), and was subject to a substrate inhibition by ribose-5'-phosphate. 
Gandhi and Westby (12) first reported evidence of the aminotransferase 
in S. typhimurium. They observed an in vitro synthesis of PRA from ribose-5 ' -
phosphate and NH
4 
Cl in a system containing a partially purified extract of GAR 
synthetase. Their work has given impetus to the present study. 
9 
The enzymatic synthesis of PRA from ribose-5'-phosphate and NH
4
Cl 
may be of general biological importance because it could provide an alternate 
means for a typical cell to produce PRA for the de novo synthesis of purines 
and other end products of the pathway (e.g., thiamine, riboflavin). In Ehrlich 
ascites cells (29), for example, it appears that the alternate route is indeed 
operative in vivo and, in fact, is quantitatively more important than the classical 
route. In gout-ridden and leukemic cells presumptive evidence indicates an 
increased rate of de novo purine biosynthesis (20, 49, 55). The answer to the 
larger question, "which route to PRA is more important in other biological 
systems ? , " would depend among other things on which enzyme was present in 
greatest concentration, the substrate Km values, and which enzyme was most 
subject to feed - back inhibition by the end products. Information on these points 
is limited, but in regard to the last item both enzymes have been shown to be 
extremely sensitive to purine nucleotides in various systems (9, 16, 49). 
/J-D-Phosphoribosylamine (PRA) and Its Conversion to GAR 
)]-D-phosphoribosylamine, the reaction product of both PP-ribose- P 
amidotransferase and ribose-5' -phosphate aminotransferase has not yet been 
isolated in any in vivo or in vitro systems because of its considerable instability. 
The amine has been prepared chemic ally, however, by the re action of ribose-
5' -phosphate with liquid ammonia under anhydrous conditions (38), and partially 
purified as the barium, calcium, or potassium salt. Absolute chemical charac-
terization has been difficult because of the presence of unreacted ribose-5' -
phosphate and ammonia in the chemically made preparations and the tendency for 
10 
the compound to break down. It has been satisfactorily preserved for periods 
of several weeks by storage in 0. 02 N KOH at low temperatures (38). 
In the de novo purine pathway, PRA is converted to glycinamide ribotide 
(GAR). This conversion was first shown in pigeon liver studies by Goldthwait 
(13) and Goldthwait et al. (14) and it was subsequently confirmed by Hartman and 
Buchanan (22), the details are summarized in equation 3. 
3 RA Gl . AT Ribosylamine-5' - phosphate:glycine ligase ) · p + ycme + p (EC 6·3 · 1.3) 
GAR + ADP + Pi 
The enzyme mediating the reaction, trivially termed GAR synthetase, has been 
purified from pigeon liver (22), A. aerogenes (45) and~- typhimurium (12). The 
reaction is reversible and the reaction mechanism has been described in detail 
by Hartman and Buchanan (23). An equilibrium constant for the reaction could 
not be obtained because of the apparent destruction of PRA, however, the con-
version of GAR to PRA is favored over its synthesis from PRA because of the 
instability of PRA which pulls the reaction in the direction of PRA. 
11 
MATERIALS AND METHODS 
Chemicals 
D-ribose-5' -phosphate as the sodium salt was obtained from the Matheson 
Company, glycine-2-
14c came from New England Nuclear Corporation, while 
hemoglobin (Sigma type 1) and beef liver catalase were gifts from Dr. B. F. 
Burnham (Utah State University). Cellex-D (DEAE cellulose) was purchased 
from Bio-Rad Laboratories, and the other resin, Dowex-50-H+ (200 to 400 mesh, 
+ 
8% cross linkage), was a gift of the Dow Chemical Company. Dowex-50-H was 
converted to the ammonium ion form by a standard procedure. 
Growth of Bacteria 
The two purine requiring strains of ~- typhimurium employed in the 
studies were pur D-55 and pur G-310. Both were obtained from the working 
collection of Dr. J. S. Gots (University of Pennsylvania). Pur D-55 lacks GAR 
synthetase (63) and is consequently unable to convert PRA to GAR (equation 3 
in literature review, p. 10 of this thesis), and pur G-310 lacks a later enzyme 
(63), formyl-GAR amidotransferase (EC 6. 3. 5. 3) and is consequently unable to 
convert formyl-GAR to 5 '-phosphoribosyl-N-formylglycinamidine. Inocula of the 
two strains were prepared by placing overnight nutrient broth cultures of each 
at a 1:100 dilution into vessels containing the E medium (500 ml) of Vogel and 
Bonner (62) supplemented with glycerol (0. 2% W /V) , thiamine (1. 0 pg/ml) and 
12 
0 
monosodium xanthine (2. 5 p-g/ml) and incubating the flasks at 37 C with bubbling 
aeration for 10- 12 hr. 
Sixty liter batches of bacterial cells for use in enzyme purification 
were prepared by inoculating 5 gallon carboys (4 carboys) containing the 
supplemented E medium with the 10- 12 hr. · inocula (1 :100 dilution), incubating 
the vessels at 37°C with bubbling aeration for 12 hr., and harvesting the cells 
by centrifugation at 3° C. After centrifugation, the cells were washed with 
1 liter of 0. 005 M sodium phosphate buffer, pH 7. 0, and then were frozen over -
night in a small amount of the same buffer made 2. 0 mM with respect to 
2-mercaptoethanol (e.g., 45 gm wet weight cells suspended in 50 ml of buffer) . 
Preparation of Extracts 
Cell-free extracts were prepared by rupturing thawed cells with a 
Bronwill homogenizer (Type 2876, Bronwill Scientific Inc., Rochester, 
New York), using the method of Doughty and Mann (10). Good cell breakage 
coupled with a satisfactory recovery of ribo se-5 '-phosphate aminotransferase 
activity was obtained when the homogenization schedule consisted of two, 
4000- cycle 2 min. runs. 
Crude extract was separated from unbroken cells and debris by centri-
fugation at 52,000 x g for 20 min. at o0 c. The protein content of crude and 
purified extracts was determined by the method of Lowry et al. (37). 
13 
Purification of Ribose-5' -Phosphate Aminotransferase 
A crude, cell-free extract of£· typhimurium, strain pur D-55, pre-
pared as described above, was used in a purification scheme to obtain a ribose-
5' -phosphate aminotransferase, free of many other enzymes. The initial 
purification techniques which were used generally follow the procedures employed 
by Reem (48) in her purification of an avian liver ribose-5 '-phosphate aminotrans-
ferase. All steps were carried out at 4°C and all buffers contained 2. 0 mM 
2-mercaptoethanol unless otherwise stated. 
Ammonium sulfate fractionation. Fifty-two milliliters of crude extract 







duce 70% saturation. The 0-70% fraction lacked aminotransferase activity, how-
ever, substantial activity was present in the supernatant (50 ml and 1. 85 mg 
protein per ml) which was dialyzed for 7 hr. against 4. 5 liters of 0. 005 M 







DEAE cellulose chromatography. A 52 ml portion of the dialyzed ex-
tract was placed on a DEAE cellulose column (2. 5 x 10 cm) previously 
equilibrated with 0. 005 M sodium phosphate buffer pH 7. 0 at 5°C. The column 
was washed with 20 ml of the same buffer followed by a 600 ml step-wise 
gradient of decreasing pH and increasing molarity. The gradient was generated 
with a gradient mixing device, having two side-by-side chambers of equal 
diameter. The mixing chamber initially contained 300 ml of 0. 005 M sodium 
phosphate buffer pH 7. 0 and the reservoir chamber, 300 ml of O. 05 M sodium 
phosphate buffer pH 6. 0. Ten milliliter fractions were collected from the 
14 
column after 72 ml of liquid lacking activity had been eluted. When 100 ml more 
had eluted, the reservoir chamber was made 0. 08 M with respect to KC1(14. 8 
gm). Following this, eluates were collected as before. From each fraction, 
0. 2 ml and 0. 4 ml samples were removed for protein estimation and assay of 
enzyme activity, respectively. The fractions demonstrating the highest activity 
(tubes No. 15 and 18, second peak fraction) were pooled (Fraction II). 
Pressure dialysis. A 40 ml sample from the DEAE cellulose column 
was added to a pressure dialysis chamber (Amicon Corporation, Diaflo model 
200) fitted with a 10,000 molecular weight exclusion ultrafilter (Diaflo PM-10, 
62 mm). Nitrogen pressure of 20 psi was applied to the filter, to force the fluid 
through the filter membrane. After most of the liquid had passed through the 
filter, the retentate was washed with 20 ml of cooled water made 2. 0 mM with 
respect to 2-mercaptoethanol. The wash was removed by further pressure 
dialysis. The dialyzates (initial and wash) contained KCl and other salts 
were discarded. The retentate, in a final volume of 2-3 ml, contained all the 
proteins of the purified extract. The volume of the retentate was readjusted to 
approximately 10 ml with cold water containing 2-mercaptoethanol (2. 0 mM) 
and pressure dialysis was repeated with a 50,000 molecular weight ultrafilter 
(Diaflo PM-50, 62 mm). Most of the proteins, including the aminotransferase, 
remained again in the retentate and after washing as above, the retentate (6 ml) 
was subjected a third time to pressure dialysis, in this case with a 100, 000 
molecular weight ultrafilter (Diaflo XM-100, 62 mm). After the retentate was 
washed a third time, an examjnation indicated the aminotransferase was still 
present in the retentate which had a volume of 7 ml and contained 160 pg 
protein/ml. This preparation was called fraction III. 
In order to have sufficient purified enzyme for substrate tests, 
15 
molecular weight analyses and kinetic measurements, the fraction III extracts 
from two similar purification runs were combined and concentrated by pressure 
dialysis with a 10,000 molecular weight ultrafilter to a protein concentration of 
200 pg/ml. 
Assay of Ribose-5 '-Phosphate Aminotransferase (for PRA Production) 
The aminotransferase catalyzing the ATP dependent conversion of 
ammonium ion and ribose-5' -phosphate to PRA was assayed indirectly with a 
coupled system owing to the instability of PRA under physiological conditions . 
14 
To accomplish the coupling, glycine- 2- C and a partially purified GAR 







~- typhimurium pur G-310 extract per assay mixture) were included in the assay 
system thereby allowing the conversion of any unstable PRA to the stable 
product GAR, according to equation 3 (in literature review, p. 10 of this thesis ). 
The GAR synthetase preparation was not entirely free from ribose-5' - phosphate 
aminotransferase , however, an appropriate control was set up in each assay 
(except in the enzyme dosage experiment) to account for the small amount of 
PRA produced from the aminotransferase contaminating the coupled system. 
A typical incubation mixture contained 30 ,.umoles tris-HCl buffer 
(pH 9. 0), 1. 2 p.moles glycine-2-
14
c (0. 0809-0. 112 µc/µmole), 2. 7 µmoles 
MgC1
2
, 1 p.mole ATP, 10 ¥moles NH
4
Cl, 5 µmoles ribose-5'-phosphate and 
the two enzyme fractions in a final volume of 0. 50 ml. 
16 
Control systems contained the same ingredients but were formulated 
without the second enzyme fraction and thus lacked the aminotransferase. The 
mixtures (test and control) were incubated at 37°c for 10 min., at which time 
0. 05 ml of 50% trichloroacetic acid was added to stop any reaction and to 
precipitate the protein. 
GAR-
14
c and any of the next de novo intermediate, formyl-GAR-
14
c 
(mixtures termed "total GAR") were separated from unreacted glycine-2-
14
c 
and measured by the method of Westby and Gots (63). Modifications included 
the use of 0. 5 x 7. 0 cm Dowex-50 ammonia columns rather than 0. 5 x 5. 0 cm 
columns and elution of the "total GAR" from these columns with 8. 0 ml of 
0. 1 N HCl wash rather than with only 3. 2 ml. Specific activity was ascertained 
from the amount of "total GAR" produced according to the method of Gandhi 
and Westby (12). The "total GAR" was assumed to be equivalent to the PRA. 
Determination of Molecular Weight of Ribose-5' -Phosphate 
Aminotransferase 
An estimate of the molecular weight of the ribose-5' -phosphate amino-
transferase of§_. typhimurium was determined by the sucrose gradient ultra-
centrifugation method of Noll (46). Sucrose gradients were prepared in 0. 05 M 
17 
tris-HCl buffer, pH 7. 5, made 2. 0 mM with respect to 2-mercaptoethanol. 
Bovine hemoglobin (0. 01 ml, 15 mg/ ml) or beef liver catalase (0. 01 ml con-
taining 13. 5 mg protein/ ml) or both, as reference standards, were included 
with the layered enzyme sample (0. 08 ml of fraction III containing 200 p-g 
protein/ml) at the time of centrifugation. Tubes were centrifuged on the Inter-
national Equipment Co., B-60 centrifuge with the SB-283 rotor (Model 488) at 
0 
40,000 rpm for 19 hr. at 3-4 C. 
To determine the location of the aminotransferase and the catalase, 
the centrifuged tubes were bottom punctured and six drop samples were col-
lected and assayed for the aminotransferase by the method described above 
and for catalase by a slight modification of the assay of Weil-Malherbe and 
Schade (40). The position of hemoglobin in centrifuged tubes was apparent 
by its color. From the position of the aminotransferase and the references, 
it was possible to calculate the molecular weight of the aminotransferase 
using the equations of Martin and Ames (41). 
18 
RESULTS 
Purification of Ribose-5' -Phosphate Aminotransferase 
To ascertain whether the NH
4
Cl and ribose-5'-phosphate dependent 
synthesis of PRA observed by Gandhi and Westby (12) in§_. typhimurium was 
enzymatic or non-enzymatic, an attempt was made to purify from the entero-
bacterium an enzyme that would catalyze the synthesis. Using the coupled 
assay described earlier, an enzyme was detected in strain pur D-55 extracts, 
which brought about the desired synthesis and whose specific activity increased 
incrementally in extracts undergoing successive purification. A summary of 
the purification procedure and the extent of purification of the aminotransferase 
at various steps is given in Table 1. 
The second step of purification, DEAE cellulose chromatography, 
served more than the other steps to purify the ribose-5 '-phosphate aminotrans-
ferase. The results of the DEAE cellulose chromatography, in terms of the 
elution of total protein and the enzyme, are indicated in Figure 2. Two peaks of 
enzyme activity were observed. 
Kinetic Studies 
To ascertain the significance of non-enzymatic PRA formation (45) in 
the assay system used in this study, increasing quantities of ribose-5' -phosphate 
aminotransferase (from fraction III) were incubated in a series of otherwise 
Table 1. Purification of ribose- 5' - phosphate aminotransferase from £· typhimurium 
PRA as "total GAR" 
Stage and procedure Volume Protein (nanomoles / mg protein) Fold purification Yield % 
1. Crude 52. 00 ml 8. 00 mg/ ml 70 1.0 100 
2. Ammonium sulfate 50. 00 ml 1. 85 mg/ ml 550 7.92 39.00 
3. DEAE cellulose 40. 00 ml 230 ,-ig/ ml 24. 6 X 10 
3 
388 19.00 
4. Pressure dialysis 10. oo· ml 2001,1g/ ml 55 X 10
3 792 2.00 
Figure 2. Elution of ribose-5 '-phosphate aminotransferase from DEAE 
cellulose column. The procedure is described in "Materials 
and Methods. " 
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identical incubation mixtures. The amount of PRA produced in each of these 
mixtures was proportional to the amount of enzyme present in that system 
except where saturating levels of the enzyme were present (Figure 3). This 
suggested that the PRA was, in fact, being produced enzymatically. Extensive 
dialysis would have removed any substrates from Fraction III, so the increased 
synthesis of PRA could not be ascribed to anything but large molecules, sup-
posedly protein, present in fraction III. As can be noted in Figure 3, some 
PRA was formed even in the absence of added aminotransferase. This could 
reflect either a non-enzymic synthesis of PRA or an enzymic synthesis from 
small amounts of the aminotransferase contaminating the coupling agent. 
The results from another kinetic experiment are indicated in Figure 4. 
In this test identical incubation mixtures containing a constant level of the amino-
transferase, coupling agent and other assay ingredients were incubated for vary-
ing periods of time. After 10 min. incubation at 37°C, the amount of PRA that 
was synthesized surprisingly decreased, and the decrease continued with 
increasing incubation time. From zero till 10 min. , the amount of PRA 
synthesized was proportional to the time of incubation and it was only after 
this, that the amount of product decreased. The reason for the decline in PRA 
production after 10 min. of incubation is unknown, but as a result of the experi-
ment all assays were run for only 10 min. 
Molecular Weight Estimation of the Enzyme 
Pressure dialysis was employed not only to purify the aminotransferase, 
but also to obtain a crude estimation of the enzymes molecular weight. On the 
F igure 3. Influence of ribose-5 '-phosphate aminotransferase concentration 
on PRA production. The conditions were as described in 
"Materials and Methods" and fraction III was employed as the 
source of the ribose- 5' - phosphate aminotransferase. At O min., 
only the coupling enzyme was added to the assay system. Each 
point on the curve represents an average measurement from two 
identical experiments and each point value actually represents an 
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Figure 4. Effect of time on PRA production. The conditions were as 
described in "Materials and Methods" and each incubation 
system contained 0. 6 pg protein of fraction III. Each point 
on the curve represents an average measurement from two 
identical experiments. 
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basis of the fact that the enzyme would not pass through a filter pad having a 
molecular weight exclusion of 100,000, the enzyme was assumed to have a 
molecular weight greater than this. A nearer approximation of the weight was 
ascertained by ultracentrifuging a sample of fraction III in a sucrose gradient 
according to the method of Noll (46 ). A value of 229,000 ~ 12,000) was obtained 
(Table 2) where beef liver catalase and bovine hemoglobin were used as refer-
ences and the molecular weight was calculated from equations derived by Martin 
and Ames (41). 
Stability of the Enzyme 
No systematic studies on the stability of the aminotransferase were 
carried out but it was observed that crude, as well as highly purified enzyme 
preparations, lost only very slight activity after storage at - 20°c for 8-10 
weeks. Repeated freezing at -20°c and thawing at r oom temperature had no 
significant effect on enzyme activity. 
Effects of Various Substrates on the Formation of PRA 
A series of qualitative and quantitative substrate studies were carried 
out with the ribose-5' - phosphate aminotransferase of fraction III and the results 
are indicated in Figure 5 and Table 3. Figure 5 shows the dosage effect of 
NH
4
Cl and ribose- 5 1- phosphate on PRA formation. This quantitative test was 
composed of two parts , one of which consisted of a series of identical assay 
mixtures containing increasing concentrations of ribose-5'-phosphate and a con-
stant concentration of NH
4
Cl and the other of which consisted of a series 
Table 2. Molecular weight of ~- typhimurium ribose-5 '-phosphate amino-
transferase 
Protein Molecular weight 
Bovine hemoglobin 68,000 
Beef liver catalase 225,000 
Ribose-5 '-phosphate aminotransferase 229,000 
25 
Note: The procedure is described in "Materials and Methods." The ribose-5'-
phosphate aminotransferase molecular weight estimation represents an 
average determined from two centrifugation runs. 
Figure 5. Influence of the concentration of the substrates on PRA 
production. The conditions were as described in "Materials 
and Methods" and each incubation mixture contained 0. 4 pg 
protein of fraction III. In the NH
4
Cl dosage response test, 
ribose- 5' - phosphate was maintained at 5 p moles/assay 
mixture while the NH
4
Cl concentration was varied from 
0-50 p- moles/assay mixture and in the ribose-5'-phosphate 
dosage response test, NH
4
Cl was maintained at 10 p moles / 
assay mixture while the ribose-5'-phosphate was varied 
from 0-20 \1 moles/ assay mixture. Each point on each 
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Note: The conditions were as described in "Materials and Methods" and 
each incubation system contained 0. 4 p.g protein of fraction III. 
In assay mixtures containing added PP- ribose-P (2 \l- moles/ assay 
mixture) and L-glutamine (10 }.l. moles/ assay mixture), there was 
no added ribose- 5 ' -phosphate or NH Cl, all other assay mixtures 
contained exogenous ribose- 5 '-phos~ate (5 )1 moles / assay mixture) 
and one particular amino donor (10 p. moles/ assay mixture). The 
concentration of methionine sulfoximine was 0. 5 p- moles/ assay 
mixture. Each value in the table represents an average measure-
ment from two identical experiments. 
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containing increasing concentrations of NH 
4 
Cl and a constant concentration of 
ribose-5'-phosphate. At higher concentrations, ribose-5'-phosphate inhibited 
PRA formation, whereas NH4Cl chloride did not demonstrate this inhibitory 
effect at higher concentrations. For each concentration of r ibose-5' -phosphate 
tested, a control was set up containing that level of the substrate and every other 




A variety of different nitrogen compounds were tested for their ability 
to participate as amino donors in PRA synthesis. L-glutamine was found to be 









Asparagine did not serve as an amino donor (Table 3 ). 
Because L-glutamine served as such a good amino donor in PRA for-
mation, it seemed possible that the aminotransferase preparation was either 
contaminated by PP-ribose-P amidotransferase, whose substrate is L-glutamine, 
or the purified preparation contained the amido-rather than the aminotransferase. 
To determine, therefore, how much, if any, amidotransferase was present in 
the purified extract, NH
4
Cl and ribose-5 '-phosphate were replaced in an 
incubation mixture by the amidotransferase substrates, L-glutamine and 
PP-ribose-P. The results show that only about 10% as much PRA as "total 
GAR" was produced under these circumstances as when ribose-5' -phosphate 
and NH
4
Cl were present. This limited PRA production could have been due to a 
contamination of fraction III or the coupling agent by low levels of the amido-
transferase. Alternatively fraction III and the coupling agent could have been 
free from contamination and the PRA that was detected in the PP-ribose-P 
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system could have been produced via the aminotransferase from L-glutamine 
and low levels of ribose- 5'-phosphate (ribose-5'-phosphate was probably present 
in the commercial PP-ribose-P preparation that was used in the assay). The 
latter hypothesis would suggest, as the substrate tests just mentioned do, that 
L-glutamine can substitute for ammonium ion as the amino donor. 
To test the adequacy of NH
4
Cl as an amino source for the aminotrans-
ferase reaction, the glutamine synthetase inhibitor, methionine sulfoximine was 
employed. Its presence in an incubation system containing NH
4
Cl as the sole 
amino donor was used to determine whether NH
4
Cl, itself, was being used as 
the amino donor or whether the NH
4
Cl was first being converted to L-glutamine. 
If NH
4
Cl was being used, thePRA reaction would not be inhibited by methionine 
sulfoximine, but on the other hand, if the NH
4
Cl was first being converted to 
L-glutamine by the synthetase and the L-glutamine was actually serving as the 
amino donor, then the reaction would be inhibited by the sulfoximine. The 
results of such a test are indicated in Table 3. As can be seen, substantial 
amounts of PRA were still formed in the presence of the sulfoximine. About 
70% of the PRA that was produced in the absence of the sulfoximine was still 
produced in its presence (81. 1 nanomoles versus 57. 7 nanomoles) . This sug-
gests that NH
4
Cl, itself, serves as an adequate amino source for the amino-
transferase reaction, it also suggests that fraction III primarily contains the 
amino rather than the amidotransferase, since the latter has a strict require-
ment for L-glutamine. 
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DISCUSSION 
GAR Production in the Coupled System 
In the present study, a purine-requiring mutant (pur-D 55) lacking GAR 
synthetase (the assay coupling agent) was purposely selected as the source of the 
aminotransferase rather than the wild type (LT-2) or another mutant. Had a 
strain been chosen that possessed both the aminotransferase and GAR synthetase 
(LT-2 or another mutant), then it would have been impossible to use the coupled 
system to assay for the aminotransferase because the GAR produced in the 
coupled system in such a case could either have been the result of: (1) the 
strain' s synthetase (utilizing non-enzymatically formed PRA), or (2) the strain ' s 
aminotransferase (through conversion of the PRA to GAR by the coupling agent): 
1) ribose-5'-phosphate + NH
4
Cl non-enzymatically> PRA synthetase )GAR 
2) ribose-5'-phosphate + NH
4
Cl aminotransferase PRA synthetase;> GAR 
By utilizing a pur-D extract it was possible to employ the coupled system with 
the knowledge that the system was not mistakenly measuring a GAR synthetase 
activity of the extract. 
That the coupled assay was indeed measuring ribose-5' -phosphate 
aminotransferase activity, and not any non-enzymic PRA formation, was 
demonstrated in the enzyme dosage-response experiment by the elevated "total 
GAR" production which occurred in response to increased fraction III 
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concentrations. The extensively purified enzyme preparation that was employed 
had been dialyzed several times so that it could not have contained significant 
amounts of the PRA substrates, and consequently the stimulatory dosage effect 
could have only been due to high molecular weight material, supposedly enzyme 
protein. But could this enzymatic material have been PP- ribose-P amidotrans -· 
ferase, which pur-D mutants do possess (63), or was it truly ribose-5 '-phosphate 
aminotransferase? If, in fact, fraction III was comprised of the amidotransfer-
ase rather than the aminotransferase, then increasing its dosage in the coupled 
system could have lead to the increased "total GAR" production that was noted. 
The aminotransferase substrates, ribose-5' -phosphate and NH 
4 
Cl , could have 
hypothetically been converted to the amidotransferase substrates, PP-ribose-P 
and L-glutamine, by contaminant enzymes either in fraction III or the coupling 
agent. Then any PP-ribose-P amidotransferase present would have converted 
these secondary substrates to PRA and the latter would have been converted to 
GAR by the coupling agent. The possibility of fraction III containing the amido-
rather than the aminotransferase seems excluded, however, by the fact that 
when ribose-5'-phosphate and NH
4
Cl were substituted by PP-ribose-P and 
L-glutamine in the coupled system, 90% less "total GAR" was produced than 
in the normal system. In addition, methionine sulfoximine, an indirect 
inhibitor of the amidotransferase reaction, only slightly inhibited GAR production 
in the normal coupled system (containing fraction III and the aminotransferase 
substrates). 
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Nierlich and Magasanik (43) observed a non-enzymic formation of PRA 
from ribose-5 '-phosphate and ammonium ion in a coupled system of their design, 
but concluded that the reaction was quantitatively insignificant in vivo in A. 
aerogenes. Assuming this to be also true in e_. typhimurium, a close relative 
to A. aerogenes, and based upon the above analysis of the present results, it is 
concluded that the alternate first step of purine biosynthesis in e_. typhimurium 
proceeds enzymically and in a manner similar to that in wheat germ (32), 
mammalian tissue (29, 49), E. coli (34) and avian liver (48). In the latter case, 
the alternate enzyme has been partially purified and completely separated from 
the L-glutamine dependent amidotransferase. The reaction mediated by the 
avian enzyme requires ammonium ion, ribose-5'-phosphate and magnesium ion, 
as does the reaction mediated by thee_. typhimurium enzyme. The reaction's 
overall contribution to purine biosynthesis, however, is still questionable in 
both systems. 
The Ribose-5' -Phosphate Aminotransferase of 
Various Organisms 
Reem (48) working with purified avian- liver ribose-5'-phosphate amino-








served as excellent nitrogen 
donors for the avian liver enzyme. L-glutamine and asparagine were much less 
effective and carbamyl-P completely failed to serve as an effective nitrogen 
donor. The e_. typhimurium enzyme shows a somewhat different pattern, as 










Cl, asparagine was completely ineffective. 
Although at variance with the avian liver studies, our results coincide almost 
exactly with what was found for the aminotransferase of another enteric 
bacterium, E. coli (34). 
The§_. typhimurium aminotransferase demonstrated the same response 
as the avian enzyme to increasing concentrations of the substrates, namely an 
inhibition to evelated ribose-5' -phosphate levels and the lack of such to elevated 
NH
4
Cl levels. Since ribose-5'-phosphate is not only involved in de novo purine 
synthesis but also plays a role in the purine salvage pathway (61), pyrimidine 
synthesis (3, 31, 42) and various other biosynthetic routes (39, 54). It seems 
reasonable that its usage would be carefully coordinated and regulated. As part 
of this coordination, there might very likely occur a feed-back inhibition on 
ribose-5 '-phosphate aminotransferase in order to restrict the flow of ribose 
for de novo purine synthesis. 
An 800-fold purification of the §_. typhimurium aminotransferase was 
achieved in the present study as compared to a 100-fold purification achieved in 
an earlier pigeon liver study by Reem (48). Substrate studies with both the 
purified bacterial (Table 3) and avian (48) enzyme indicate that ribose-5' -
phosphate, and not PP-ribose-P, serves as the pentose acceptor in the amino-
transferase reaction. 
Ribose-5 '-Phosphate Aminotransferase Versus 
PP-ribose-P Amidotransferase 
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PRA can be formed in_§_. typhimurium, not only through the mediation 
of ribose-5 '-phosphate aminotransferase but also through the mediation of 
PP-ribose-P amidotransferase (15). The latter enzyme requires PP-ribose-F 
and L-glutamine to form PRA, ribose-5 ' -phosphate and NH
4
Cl will not substitute, 
and the reaction seems to provide the main route for PRA production (17). 
The amidotransferase of pigeon liver has a molecular weight of 200,000 
(52) and the enzyme readily dissociates into two 100,000 molecular weight 
dimers whose monomers have a molecular weight of 50, 000. The S. typhimurium 
aminotransferase has an approximate molecular weight of 229,000. Perhaps, 
the §_. typhimurium ribose-5' -phosphate aminotransferase also dissociates, 
since in the second step of purification involving DEAE cellulose chromatography, 
two peaks of enzyme activity were observed. An alternative possibility is that 
two isozymes of the aminotransferase exist in_§. typhimurium. 
Feed-back Inhibition 
Different workers (15, 16, 44, 48, 49, 56, 65) have demonstrated feed-
back inhibition not only of the classical first step, but also of the alternate first 
st ep of de novo purine synthesis. Purified preparations of pigeon liver amino-
transferase were shown to be inhibited by purines and their derivatives, the 
nucleotides being more effective than the bases (48). AMP and ATP at con-
centrations of 4. 0 ,p.M inhibited the enzyme reaction 80 and 87 per cent, 
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respectively, whereas GMP at a concentration of 2. 0 mM inhibited the reaction 
only 30 per cent. ATP was ineffective as an inhibitor and AMP-GMP mixtures 
exerted no synergistic effect, only an additive one. The situation is somewhat 
different with regard to pigeon liver amidotransferase, here a wider variety of 
nucleotides are effective inhibitors at the above concentrations (e.g., AMP, 
ADP, ATP, GMP, GDP, and IMP) and AMP-GMP mixtures do exert a 
synergistic inhibitory effect (9, 15, 64). In addition, it was found that the 
nucleotides acted as competitive inhibitors of the amidotransferase substrate, 
PP-ribose-P. 
In bacterial systems, feed-back inhibition of the amidotransferase has 
been observed in enzyme extracts from Bacillus subtilis (51, 56), §_. typhimurium 
(15, 17) and A. aerogenes (44). The enzyme from§_. typhimurium is inhibited 
by various nucleotides, of which ADP, GMP, GTP, and AMP are the most 
effective (15). A similar pattern of end-product inhibition has been observed 
with the partially purified enzyme from .f. coli (15, 34) and it was suggested 
that the ATP/ADP ratio might be of primary importance. 
CONCLUSIONS 
1. In vitro kinetic studies indicate that part, if no1 most, of the /J-D-phospho-
ribosylamine (PRA) synthesized from ribose-5' -phosphate and ammonium 
ion in_§. typhimurium is formed enzymically rather than non-enzymically. 
2. The involved enzyme, ribose-5'-phosphate aminotransferase, has been 
purified about 800 .. fold from extracts of§_. typhimurium (pur D-55) and is 
distinct from ribosy lpyrophosphate 5 '-phosphate amidotransf erase (EC 
2. 4. 1. 14) which is found in the same organism, but which catalyzes the 
formation of PRA from PP-ribose-P and L-glutamine. 
3. The most highly purified preparation of the aminotransferase (fraction III) 
was either uncontaminated by the amidotransferase or was contaminated 
by only very small quantities of the enzyme. 
4. Alternate amino donors for the aminotransferase reaction, in the order of 









Cl. L-asparagine would not serve as an amino donor. 
5. Ammonium ion could be used directly as an amino donor in the aminotrans-
ferase reaction without prior conversion to L-glutamine. 
6. The aminotransferase was not inhibited by higher concentrations of NH
4
Cl, 
but was drastically inhibited by higher concentrations (above 5 )1 moles/ 
assay mixture) of ribose-5' -phosphate. 
7. The aminotransferase has an approximate molecular weight of 229,000 
(.±:. 12,000) as determined by ultrafiltration and sucrose gradient ultra-
centrifugation. 
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8. A coupled assay, employing a partially purified GAR synthetase extract 
from another §_. typhimurium strain as the source of the coupling agent , 
was used to measure the enzyme. For unknown reasons, PRA pr oduction 
decreased after 10 min. incubation at 37°C in this system. 
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